Literature DB >> 22095892

Development and status of health insurance systems in China.

Sarah L Barber1, Lan Yao.   

Abstract

Health insurance programs have changed rapidly over time in China. Among rural populations, insurance coverage shifted from nearly universal levels in the 1970s to 7% in 1999; it stands at 94% of counties in 2009. This large increase is the result of a series of health reforms that aim to achieve universal access to healthcare and better risk protection, largely through the rollout of the health insurance programs and the gradual increase in subsidies and benefits over time. In this paper, we present the development of the rural and urban health insurance programs, their modes of financing and operation and the benefits and reimbursement schemes at the end of 2009. We discuss some of the problems with the rural and urban residents' schemes including reliance on local government capacity, reimbursement ceilings and rates, and incentives for unnecessary care and waste in the design of the programs. Recommendations include increasing financial support and deepening the benefits packages. Strategies to control cost and improve quality include developing mixed provider payment mechanisms, implementing essential medicines policies and strengthening the quality of primary-care provision.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22095892     DOI: 10.1002/hpm.1109

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  26 in total

1.  Development and Validation of a Simplified Chinese Version of the Assessment Tool for Students' Perceptions of Medical Professionalism.

Authors:  Fei-Fei Yu; Chun-Yan Du; Zi-Feng Liu; Li-Jin Chen; Yi-Xiang Huang; Ling-Ling Zhang
Journal:  Curr Med Sci       Date:  2019-07-25

2.  The political economy of healthcare reform in China: negotiating public and private.

Authors:  Arthur Daemmrich
Journal:  Springerplus       Date:  2013-09-10

3.  Chronic conditions and receipt of treatment among urbanized rural residents in China.

Authors:  Juan Chen
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

4.  Trends in hypertension prevalence, awareness, treatment, and control rates in Shandong Province of China.

Authors:  Yong Zhao; Fanghong Lu; Hui Sun; Zhendong Liu; Yingxin Zhao; Shangwen Sun; Shujian Wang; Yutao Diao; Hua Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-13       Impact factor: 3.738

5.  Changes in health expenditures in China in 2000s: has the health system reform improved affordability.

Authors:  Qian Long; Ling Xu; Henk Bekedam; Shenglan Tang
Journal:  Int J Equity Health       Date:  2013-06-13

6.  Access to healthcare and medical expenditure for the middle-aged and elderly: observations from China.

Authors:  Yan Jiang; Yu Wang; Le Zhang; Yang Li; Xiaojun Wang; Shuangge Ma
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

7.  China's new cooperative medical scheme and equity in access to health care: evidence from a longitudinal household survey.

Authors:  Wei Yang
Journal:  Int J Equity Health       Date:  2013-03-23

8.  Integrating traditional chinese medicine services in community health centers: insights into utilization patterns in the pearl river region of china.

Authors:  Vincent C H Chung; Polly H X Ma; Harry H X Wang; Jia Ji Wang; Lau Chun Hong; Xiaolin Wei; Samuel Y S Wong; Jin Ling Tang; Sian M Griffiths
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-20       Impact factor: 2.629

9.  Tuberculosis Hospitalization Fees and Bed Utilization in China from 1999 to 2009: The Results of a National Survey of Tuberculosis Specialized Hospitals.

Authors:  Jian Du; Dirlikov Emilio; Yu Pang; Yan Ma; Fengling Mi; Yuhong Liu; Liang Li
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

10.  Health insurance utilization and its impact: observations from the middle-aged and elderly in China.

Authors:  Yu Wang; Yan Jiang; Yang Li; Xiaojun Wang; Chi Ma; Shuangge Ma
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.